Advanced HIV Infection in Treatment-Naïve Individuals: Effectiveness and Persistence of Recommended 3-Drug Regimens.
Karam MounzerLaurence BrunetJennifer S FuscoIan R McnichollHelena Diaz CuervoMichael SensionLewis MccurdyGregory P FuscoPublished in: Open forum infectious diseases (2022)
Among people with advanced HIV infection, those initiating B/F/TAF were less likely to discontinue/modify their regimen than those on any other regimen, and more likely to achieve viral suppression compared with those on bDRV but not compared with those on other integrase inhibitors.